⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Lost Money on MoonLake Immunotherapeutics (MLTX)? Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
CLASS ACTION REMINDER: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Lawsuit by December 15, 2025
prnewswire.com
MLTX
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
prnewswire.com
MLTX
Levi & Korsinsky Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX
prnewswire.com
MLTX
SueWallSt Podcast Update: Levi & Korsinsky Details MLTX Class Action Claims
accessnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics (MLTX)? Urged to Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Calls Attention to Class Action Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Class Action Alert: Levi & Korsinsky Reminds MoonLake (MLTX) Investors of December 15, 2025 Deadline
accessnewswire.com
MLTX